ABBV vs COST: Which Is the Better Buy?
Side-by-side comparison of AbbVie Inc. and Costco Wholesale Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-04-29.
AbbVie Inc. · Healthcare
$197.69
+6.3% upside to fair value
Grade C
High Quality
VS
Costco Wholesale Corporation · Consumer Defensive
$999.89
-20.7% upside to fair value
Grade D
High Quality
QuantHub Verdict
ABBV has more upside to fair value
(+6.3%).
COST trades at a lower forward P/E
(51.9x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ABBV |
COST |
| Current Price |
$197.69 |
$999.89 |
| Fair Value Estimate |
$210.22 |
$793.02 |
| Upside to Fair Value |
+6.3%
|
-20.7%
|
| Market Cap |
$349.7B |
$443.6B |
| Forward P/E |
83.3x
|
51.9x
|
| EV / EBITDA |
23.4x
|
30.9x
|
| Price / Sales |
5.7x
|
1.6x
|
| Price / FCF |
18.7x
|
48.8x
|
| Revenue Growth YoY |
+10.0%
|
+9.2%
|
| Gross Margin |
70.2%
|
12.9%
|
| Operating Margin |
26.7%
|
3.8%
|
| Return on Equity |
-361.6%
|
28.8%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
5.35%
|
2.05%
|
| Analyst Consensus |
Strong Buy
|
Buy
|
Investment Thesis
AbbVie Inc. is a leading healthcare company specializing in drug manufacturing with a strong focus on immunology, neuroscience, oncology, and aesthetics. The company benefits from a durable competitive moat driven by blockbuster drugs such as Skyrizi and Rinvoq, which are experiencing rapid growth and offsetting declines from Humira due to biosimilar competition. Despite a high trailing and forwa…
Costco Wholesale Corporation operates a global membership-based warehouse club model that leverages scale, low costs, and superior employee retention to deliver consistent revenue and earnings growth. The company reported $269.9 billion in net sales for fiscal 2025 with an 8% year-over-year increase, driven by strong segments in Foods and Sundries and membership fees exceeding $5.65 billion in th…
Accumulation Zones
| Metric |
ABBV |
COST |
| Zone Low |
$157.66 |
$594.76 |
| Zone High |
$178.69 |
$674.07 |
| In Buy Zone? |
No
|
No
|